Navigation Links
Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company
Date:3/8/2011

0;Cellceutix owns the rights to eight drug compounds, including Kevetrin, which it is developing as a treatment for certain cancers, KM-133, for the treatment of psoriasis, and KM-391, for the treatment of autism.  More information is available on the Cellceutix web site at www.cellceutix.com.

Kevetrin, KM133, and KM-391 have not been studied in humans at this time. The Company's positive results in animal studies do not necessarily guarantee success in humans, though they may form the basis for beginning Phase 1 trials.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by Cellceutix Corporation are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading
'/>"/>

SOURCE Cellceutix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cellceutix Discovers Drug Activates Guardian Angel p53 in Fight Against Leukemia
2. Cellceutix Cancer Drug Kevetrin™ Shows No Genotoxicity in Study
3. Sequenom Reports Fourth Quarter and Full Year 2010 Financial Results
4. Cumberland Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
5. RBC Life Sciences Reports Sales and Earnings Growth in 2010
6. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results
7. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
8. IRIDEX Reports Strong Growth and Profits in 2010 Fourth Quarter
9. China Pharma Holdings, Inc. Reports Full Year 2010 Financial Results
10. Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
11. Assured Pharmacy Reports Same Store Sales for the Month of December 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... VEGAS , March 26, 2015 Zimmer ... Vivacit-E ® Advanced Bearing Technology with ... A paper published earlier this month reported that, ... Vivacit-E Advanced Bearing Technology featuring Vitamin E ... maintained a significant wear rate reduction of 95 percent, ...
(Date:3/26/2015)... WASHINGTON , March 26, 2015 Even ... anniversary of the Food and Drug Administration,s landmark approval ... from 11 members of Congress calling on the Agency ... approving a first-ever medical treatment for women,s most common ... 26 FDA-approved medical treatment options for sexual dysfunction – ...
(Date:3/26/2015)... , March 26, 2015 ... and Drug Safety Software Market by Functionality (Adverse Event ... based (SAAS)), End-user (Pharma & Biotech Companies, CROs, ... MarketsandMarkets, the Pharmacovigilance and Drug Safety Software Market ... 6.5% during 2014-2019, and is expected to reach ...
Breaking Medicine Technology:Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 2Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 3Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health 4Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 2Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 3Pharmacovigilance and Drug Safety Software Market Worth $154.1 Million by 2019 4
... a corporate mission of saving 100,000 more lives each year, ... leading manufacturer of medical devices and software for treating cancer ... expand its corporate branding efforts by tapping advertising agency DeVito/Verdi ... will be handled by the New York City-based agency,s San ...
... May 9, 2011 NxStage Medical, Inc. (Nasdaq: ... innovative dialysis products, today expressed its support for ... educate U.S. Congressional policymakers and their advisors about ... hemodialysis. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO) On ...
Cached Medicine Technology:Leading Medical Device and Software Manufacturer Looks to Build Its Brand With DeVito/Verdi 2Leading Medical Device and Software Manufacturer Looks to Build Its Brand With DeVito/Verdi 3NxStage® Supports Initiative by Patient Advocacy Groups to Educate Policymakers about the Benefits of Frequent Home Hemodialysis 2
(Date:3/26/2015)... Frencisco, CA (PRWEB) March 26, 2015 ... Center are proud to announce expanded offerings for Bay ... San Francisco Dental Implant Center has long been a ... have expanded its offerings to meet the strong demand ... in our reputation as a top-rated dental implant facility ...
(Date:3/26/2015)... Springs, FL (PRWEB) March 26, 2015 ... of the nation’s leading innovative specialty pharmacies, announces ... created position of Vice President of Pharmaceutical Relations. ... fostering beneficial connections with our pharmaceuticals partners and ... relationships in support of BioPlus’ expansion. , ...
(Date:3/26/2015)... In the key developed markets, the hypertension market value ... to decrease through 2020 at a negative CAGR (0.9%) to ... to 2017 at a 2.6% CAGR and a decline thereafter. ... surging penetration of fixed-dose combination drugs like Azor, Amturnide, Exforge ... and Tekamlo), a hike in the prevalence population to 190 ...
(Date:3/26/2015)... 2015 Leading nutritional supplement provider ... website: http://www.metabolicnutrition.com . The ultramodern, clean ... a user-friendly experience for consumers seeking information about ... new, enhanced Metabolic Nutrition website includes: , ... diverse line of products, conveniently broken down by ...
(Date:3/26/2015)... 26, 2015 Zane Benefits, the leader ... a new eBook, “The Comprehensive Guide To Interviewing For ... is the most important aspect of the hiring process. ... hiring the right way, possibly resulting in thousands of ... arduous undertaking, yet it’s essential to the success of ...
Breaking Medicine News(10 mins):Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 3Health News:Metabolic Nutrition Launches Sleek New Website with New Features and Enhanced Consumer Information 2Health News:Zane Benefits Announces: New eBook: The Comprehensive Guide To Interviewing For Your Small Business 2
... Reporter , MONDAY, May 9 (HealthDay News) -- Having long ... disease known as amyotrophic lateral sclerosis (ALS), British researchers report. ... mean people with long ring fingers will develop the disease ... it. "We have not done a study that shows ...
... A new study of U.S. veterans ages 70 and ... current colon cancer screening methods. However, for many less healthy ... "This study shows that we really need to target screening ... get screened and followed-up while those who won,t benefit aren,t ...
... Holohan HealthDay Reporter , MONDAY, May 9 (HealthDay ... torment suffered by people with a chronic bowel disease, a ... University of North Carolina at Chapel Hill, found that women ... than a 38 percent reduction in symptoms, far surpassing a ...
... with torture is prohibited by international law and professional ... for doctors to do, argue two bioethicists. Their timely ... as news of the trail leading to the death ... Bay who were subject to "enhanced interrogation techniques," which ...
... HealthDay Reporter , MONDAY, May 9 (HealthDay News) -- A ... other males to have been diagnosed with and then survive a ... people may face. It,s not the first time that researchers ... men, of course, are at higher risk of becoming infected with ...
... Spanish . , Ann Arbor, Mich. Wealth, ... hospice care available in a county, according to a study ... this month. Local availability is an important predictor ... have been shown to improve pain control, maintain patients, independence ...
Cached Medicine News:Health News:Ring Finger Length Linked to ALS, Study Suggests 2Health News:Ring Finger Length Linked to ALS, Study Suggests 3Health News:Blood test for colon cancer screening beneficial for some seniors, but not for many others 2Health News:Mindful Meditation Might Ease Irritable Bowel Syndrome 2Health News:Mindful Meditation Might Ease Irritable Bowel Syndrome 3Health News:A grim dilemma: Treating the tortured prisoner 2Health News:A grim dilemma: Treating the tortured prisoner 3Health News:Gay Men More Likely to Have Had Cancer 2Health News:Supply of hospice services strongly associated with local area's median household income 2
Transcranial vascular DWL doppler....
... is an automated system capable of handling ... definition of many of the tests allows ... your patients' and staffs' needs. Any tests ... automated tests can easily be handled using ...
The CD Horizon M10 Spinal System provide spine surgeons comprehensive solutions for the treatment of spinal deformities, trauma reconstruction, and degenerative conditions....
... Neurocare - continues the revolutionary ... Exceptional convenience and speed. Superior Doppler ... delivers features you won't find anywhere ... cuff attachment and testing. Up to ...
Medicine Products: